Zhejiang Gongdong Medical Technology Co Ltd (605369) - Net Assets
Based on the latest financial reports, Zhejiang Gongdong Medical Technology Co Ltd (605369) has net assets worth CN¥1.74 Billion CNY (≈ $253.94 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.19 Billion ≈ $319.97 Million USD) and total liabilities (CN¥451.25 Million ≈ $66.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See 605369 net asset quality score to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.74 Billion |
| % of Total Assets | 79.36% |
| Annual Growth Rate | 27.77% |
| 5-Year Change | 22.92% |
| 10-Year Change | N/A |
| Growth Volatility | 58.58 |
Zhejiang Gongdong Medical Technology Co Ltd - Net Assets Trend (2016–2025)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Zhejiang Gongdong Medical Technology Co worth.
Annual Net Assets for Zhejiang Gongdong Medical Technology Co Ltd (2016–2025)
The table below shows the annual net assets of Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2025. Also explore how fast is Zhejiang Gongdong Medical Technology Co growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.71 Billion ≈ $249.68 Million |
-0.66% |
| 2024-12-31 | CN¥1.72 Billion ≈ $251.33 Million |
+4.82% |
| 2023-12-31 | CN¥1.64 Billion ≈ $239.77 Million |
+2.91% |
| 2022-12-31 | CN¥1.59 Billion ≈ $232.99 Million |
+14.71% |
| 2021-12-31 | CN¥1.39 Billion ≈ $203.11 Million |
+14.91% |
| 2020-12-31 | CN¥1.21 Billion ≈ $176.76 Million |
+198.07% |
| 2019-12-31 | CN¥405.25 Million ≈ $59.30 Million |
+18.69% |
| 2018-12-31 | CN¥341.42 Million ≈ $49.96 Million |
+35.21% |
| 2017-12-31 | CN¥252.52 Million ≈ $36.95 Million |
+34.27% |
| 2016-12-31 | CN¥188.07 Million ≈ $27.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang Gongdong Medical Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 797.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥758.92 Million | 44.95% |
| Other Components | CN¥929.57 Million | 55.05% |
| Total Equity | CN¥1.69 Billion | 100.00% |
Zhejiang Gongdong Medical Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Zhejiang Gongdong Medical Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo KUO S.A.B. de C.V
MX:KUOB
|
$572.75 Million |
|
W olf Photoelectric Technology Ltd
SHE:002962
|
$572.76 Million |
|
Meorient
SHE:300795
|
$572.96 Million |
|
Guangdong Mingzhu Group Co Ltd
SHG:600382
|
$573.10 Million |
|
Shandong Sunway Petrochemical Engineering Co Ltd
SHE:002469
|
$572.54 Million |
|
Cardinal Infrastructure Group Inc. Class A Common Stock
NASDAQ:CDNL
|
$572.41 Million |
|
Telefonica Chile S.A.
SN:CTC
|
$572.22 Million |
|
Nanjing Huamai Tech Co Ltd
SHG:603042
|
$572.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang Gongdong Medical Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,707,180,400 to 1,688,489,303, a change of -18,691,097 (-1.1%).
- Net income of 51,507,175 contributed positively to equity growth.
- Dividend payments of 65,680,631 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥51.51 Million | +3.05% |
| Dividends Paid | CN¥65.68 Million | -3.89% |
| Other Changes | CN¥-4.52 Million | -0.27% |
| Total Change | CN¥- | -1.09% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang Gongdong Medical Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.32x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.54x to 2.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥1.14 | CN¥17.75 | x |
| 2017-12-31 | CN¥1.54 | CN¥17.75 | x |
| 2018-12-31 | CN¥2.08 | CN¥17.75 | x |
| 2019-12-31 | CN¥2.46 | CN¥17.75 | x |
| 2020-12-31 | CN¥6.79 | CN¥17.75 | x |
| 2021-12-31 | CN¥6.31 | CN¥17.75 | x |
| 2022-12-31 | CN¥7.25 | CN¥17.75 | x |
| 2023-12-31 | CN¥7.40 | CN¥17.75 | x |
| 2024-12-31 | CN¥7.74 | CN¥17.75 | x |
| 2025-12-31 | CN¥7.66 | CN¥17.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang Gongdong Medical Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.54%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.25x
- Recent ROE (3.05%) is below the historical average (18.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 32.18% | 16.30% | 1.05x | 1.87x | CN¥41.71 Million |
| 2017 | 21.58% | 12.63% | 1.31x | 1.30x | CN¥29.23 Million |
| 2018 | 25.09% | 17.75% | 1.04x | 1.36x | CN¥51.53 Million |
| 2019 | 28.03% | 20.54% | 1.03x | 1.32x | CN¥73.06 Million |
| 2020 | 18.70% | 27.23% | 0.60x | 1.14x | CN¥105.09 Million |
| 2021 | 22.40% | 26.04% | 0.71x | 1.22x | CN¥172.18 Million |
| 2022 | 20.48% | 22.20% | 0.79x | 1.17x | CN¥166.82 Million |
| 2023 | 6.66% | 11.19% | 0.52x | 1.15x | CN¥-54.73 Million |
| 2024 | 10.05% | 15.39% | 0.57x | 1.14x | CN¥914.76K |
| 2025 | 3.05% | 4.54% | 0.54x | 1.25x | CN¥-117.34 Million |
Industry Comparison
This section compares Zhejiang Gongdong Medical Technology Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,285,039,921
- Average return on equity (ROE) among peers: 9.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang Gongdong Medical Technology Co Ltd (605369) | CN¥1.74 Billion | 32.18% | 0.26x | $572.70 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.74 Billion | 2.80% | 1.18x | $498.13 Million |
| Blue Sail Medical Co Ltd (002382) | $1.18 Billion | 14.38% | 0.26x | $877.28 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $4.21 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.21 Billion | 3.44% | 0.58x | $792.30 Million |
| Guangzhou Improve Med Instrument (300030) | $1.00 Billion | 16.21% | 0.74x | $308.11 Million |
| QITIAN Technology Group Co Ltd (300061) | $2.47 Billion | -32.17% | 0.22x | $649.95 Million |
| Shanghai Tofflon Science Tech (300171) | $211.83 Million | 35.82% | 1.54x | $1.79 Billion |
| Truking Technology Ltd (300358) | $832.98 Million | 18.84% | 0.72x | $1.00 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.16 Billion | 15.98% | 0.55x | $689.10 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $290.70 Million | 15.03% | 0.44x | $1.29 Billion |
About Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more